PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences

Rhea-AI Summary

PTC Therapeutics, trading under NASDAQ: PTCT, will present an overview at two upcoming virtual conferences. The Credit Suisse 29th Annual Virtual Healthcare Conference is scheduled for November 11, 2020, at 9:30 a.m. ET, and the Barclays Virtual Gene Editing & Gene Therapy Summit will occur on November 16, 2020, at 3:30 p.m. ET. These presentations will be streamed live and archived for two weeks on PTC's investor relations webpage. PTC focuses on developing innovative therapies for patients with rare disorders.

SOUTH PLAINFIELD, N.J., Oct. 28, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences:

Credit Suisse 29^th Annual Virtual Healthcare Conference
Wednesday, November 11^th at 9:30 a.m. ET

Barclays Virtual Gene Editing & Gene Therapy Summit
Monday, November 16^th at 3:30 p.m. ET 

The presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:
Media:	Investors:
Jane Baj	Lisa Hayes
+1 (908) 912-9167	+1 (732) 354-8687
jbaj@ptcbio.com	lhayes@ptcbio.com

 

View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-virtual-investor-conferences-301160900.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTCT present at the Credit Suisse Virtual Healthcare Conference?

PTC Therapeutics will present at the Credit Suisse 29th Annual Virtual Healthcare Conference on November 11, 2020, at 9:30 a.m. ET.

What is the date of the Barclays Virtual Gene Editing & Gene Therapy Summit for PTCT?

The Barclays Virtual Gene Editing & Gene Therapy Summit for PTC Therapeutics is scheduled for November 16, 2020, at 3:30 p.m. ET.

Where can I watch PTCT's conference presentations?

PTC Therapeutics' conference presentations will be webcast live on their investor relations website and archived for two weeks after the events.

What is the focus of PTC Therapeutics?

PTC Therapeutics focuses on discovering and developing innovative therapies for patients with rare disorders.

What does NASDAQ: PTCT represent?

NASDAQ: PTCT represents the stock symbol for PTC Therapeutics, a biopharmaceutical company.